Delivery Order SPE2DB20D3303-SPE2DB25FY2S3
Award Date
11/1/24
Potential Completion Date
11/4/24
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Renflexis 100 mg vials. The contract has a ceiling value of $6,529.60 and runs through November 24, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 mg vials of the medication Renflexis. The contract has a ceiling value of $10,392.66 and a period of performance through July 2, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive pharmaceutical support vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RENFLEXIS 100 MG VIALS. The contract has a ceiling value of $4,546.54 and a period of performance ending on June 25, 2025. The contract is not set aside and was awarded on June 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $10,907.52, is for the supply of the pharmaceutical product Renflexis 100 mg vials. The ultimate completion date is July 22, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Renflexis 100 mg vials. The contract is a firm fixed-price delivery order with a ceiling value of $8,516.00 and a period of performance through April 30, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 mg vials of the drug Renflexis, with a ceiling value of $44,373.92 and a performance period through September 29, 2023. This contract is a delivery order awarded under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Renflexis 100 mg vials. The contract has a ceiling value of $3,941.28 and a completion date of January 31, 2022. It is a firm fixed-price contract without any set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,608.36 firm fixed-price delivery order is for the supply of Renflexis 100 mg vials, a specialty medication. The contract has a period of performance running through January 23, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of RENFLEXIS 100 MG VIALS, a pharmaceutical product, with a ceiling value of $3,131.50 and an ultimate completion date of June 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 mg vials of the drug Renflexis. The contract has a ceiling value of $6,958.00 and a performance period ending on June 23, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...